Context Therapeutics® and Wisconsin Oncology Network Announce First Patient Dosed in Phase 2 ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 5 - Gina Cestari News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gina Cestari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gina Cestari Today - Breaking & Trending Today
BioVaxys Announces BVX-0320 Poster Presentation at ISIRV-WHO Virtual Conference
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that a poster highlighting its...
Source: prnewswire.com
BioVaxys Technology Corp.: BioVaxys Announces BVX-0320 Poster Presentation at ISIRV-WHO Virtual Conference
SARS-Cov-2 spike protein vaccine induced strong antibody and T cell responses in murine model VANCOUVER, BC, Oct. 8, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB,
Source: finanznachrichten.de
WindMIL Therapeutics Appoints Dr. Kimberly Noonan as Chief
WindMIL Therapeutics Appoints Dr. Kimberly Noonan as Chief Science & Technology Officer May 06, 2021 07:00 ET | Source: WindMIL Therapeutics WindMIL Therapeutics Philadelphia, Pennsylvania, UNITED STATES PHILADELPHIA and BALTIMORE, May 06, 2021 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs ®) for cancer immunotherapy, today announced the appointment of Co-Founder Kimberly Noonan, PhD, MPH, to Executive Vice President, Chief Science & Technology Officer. In this role, Dr. Noonan...
Source: globenewswire.com